Atmospheric particulate matter may influence the transmission and evolution of SARS-CoV-2

NewsGuard 100/100 Score

A recent study conducted at the University of Malta Medical School, Malta, has revealed that a drop in the level of particulate matter 2.5 (PM2.5), which are airborne pollutant particles with a diameter of 2.5 micrometers, in the atmosphere due to lockdown is associated with the arrival of a newer variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has eventually displaced the original virus after lockdown. The new viral variant (D614G mutant) may be able to use other types of PM, including the one that originated from tobacco smoking, as a viral vector for transmission. The study is currently available on the medRxiv* preprint server.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Background

As the COVID-19 pandemic continues exponentially, a second wave of SARS-CoV-2 infection has been observed in many countries globally. This could be due to the relaxation made by government bodies on control measures during the later phases of the pandemic. In addition to an increase in COVID-19 incidence, a rise in pollution level has also been observed during the post-lockdown phase. In this context, several environmental studies have shown the SARS-CoV-2 uses PM2.5 as a viral vector for transmission and that an increase in atmospheric PM2.5 level is associated with an induction in new COVID-19 cases in many cities in China. Moreover, there is evidence suggesting that PM2.5 may disrupt the pulmonary microbial defense system, which in turn may facilitate SARS-CoV-2 to invade and infect the respiratory system.

Current study design

The current study has been conducted to investigate whether an alteration in atmospheric PM2.5 level can influence the evolution of SARS-CoV-2 as well as its ability to infect host cells.

The scientists have used the Air Quality Index to obtain average PM2.5 levels in selective cities including Beijing, Sheffield, Nottingham, Sydney and Cambridge. In addition, they collected information about daily viral counts of the original and newer SARS-CoV-2 variants from the available literature.

Important observations

The study findings reveal that a concomitant increase in viral counts occurs with the rise in the atmospheric level of PM2.5 in the majority of cities, except Beijing. In these cities, a low baseline PM2.5 level has been observed before the rise in viral counts. This indicates that PM2.5 may serve as a potent viral vector that facilitates the transmission of SARS-CoV-2.

A different pattern has been observed in Beijing, wherein a 36% reduction in PM2.5 level has been observed when the viral count is decreased.

In the cities studied, a significant reduction in PM2.5 level has been observed after one week of regional and national lockdown.

Importantly, the arrival of a newer viral variant (D614G) has been found to coincide with declining PM2.5 levels. In Beijing, a highly increased PM2.5 level mainly correlates with the original SARS-CoV-2 but not with the mutant variant. In contrast, a correlation between the viral mutant and PM2.5 level has been observed in Sydney and Cambridge. In Sheffield and Nottingham, both the original and mutant forms of SARS-CoV-2 correlate with the PM2.5 level.    

Study significance

The study findings highlight the role of environmental pollution, including PM2.5 level in influencing the transmission of SARS-CoV-2. In addition, PM2.5 seems to play a role in manipulating viral evolution. The original viral variant was the predominant one when the PM2.5 level was highly elevated. In contrast, the mutant variant gradually displaced the original form and became predominant when the PM2.5 level was decreased.

Several genetic studies sequencing the genome of SARS-CoV-2 have indicated that more than 13,000 mutations have already occurred over a period of less than a year. Such fast-occurring genetic mutations suggest a possibility of environmental adaptation of the virus as a part of natural selection. Therefore, it is possible that a change in atmospheric PM2.5 level serves as a driving force for both viral transmission and evolution.       

Based on the study findings, the scientists suggest that the mutant SARS-CoV-2 may be utilizing other sources of PM, such as tobacco smoke-derived PM, as a viral vector to support transmission.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • Apr 3 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Dr. Sanchari Sinha Dutta

Written by

Dr. Sanchari Sinha Dutta

Dr. Sanchari Sinha Dutta is a science communicator who believes in spreading the power of science in every corner of the world. She has a Bachelor of Science (B.Sc.) degree and a Master's of Science (M.Sc.) in biology and human physiology. Following her Master's degree, Sanchari went on to study a Ph.D. in human physiology. She has authored more than 10 original research articles, all of which have been published in world renowned international journals.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dutta, Sanchari Sinha Dutta. (2023, April 03). Atmospheric particulate matter may influence the transmission and evolution of SARS-CoV-2. News-Medical. Retrieved on May 01, 2024 from https://www.news-medical.net/news/20210112/Atmospheric-particulate-matter-may-influence-the-transmission-and-evolution-of-SARS-CoV-2.aspx.

  • MLA

    Dutta, Sanchari Sinha Dutta. "Atmospheric particulate matter may influence the transmission and evolution of SARS-CoV-2". News-Medical. 01 May 2024. <https://www.news-medical.net/news/20210112/Atmospheric-particulate-matter-may-influence-the-transmission-and-evolution-of-SARS-CoV-2.aspx>.

  • Chicago

    Dutta, Sanchari Sinha Dutta. "Atmospheric particulate matter may influence the transmission and evolution of SARS-CoV-2". News-Medical. https://www.news-medical.net/news/20210112/Atmospheric-particulate-matter-may-influence-the-transmission-and-evolution-of-SARS-CoV-2.aspx. (accessed May 01, 2024).

  • Harvard

    Dutta, Sanchari Sinha Dutta. 2023. Atmospheric particulate matter may influence the transmission and evolution of SARS-CoV-2. News-Medical, viewed 01 May 2024, https://www.news-medical.net/news/20210112/Atmospheric-particulate-matter-may-influence-the-transmission-and-evolution-of-SARS-CoV-2.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study shows slight increase in Guillain-Barre syndrome risk with adenovirus COVID vaccines